These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22464254)

  • 1. Primate genome gain and loss: a bone dysplasia, muscular dystrophy, and bone cancer syndrome resulting from mutated retroviral-derived MTAP transcripts.
    Camacho-Vanegas O; Camacho SC; Till J; Miranda-Lorenzo I; Terzo E; Ramirez MC; Schramm V; Cordovano G; Watts G; Mehta S; Kimonis V; Hoch B; Philibert KD; Raabe CA; Bishop DF; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2012 Apr; 90(4):614-27. PubMed ID: 22464254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diaphyseal medullary stenosis with malignant fibrous histiocytoma: a hereditary bone dysplasia/cancer syndrome maps to 9p21-22.
    Martignetti JA; Desnick RJ; Aliprandis E; Norton KI; Hardcastle P; Nade S; Gelb BD
    Am J Hum Genet; 1999 Mar; 64(3):801-7. PubMed ID: 10053015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant fibrous histiocytoma: inherited and sporadic forms have loss of heterozygosity at chromosome bands 9p21-22-evidence for a common genetic defect.
    Martignetti JA; Gelb BD; Pierce H; Picci P; Desnick RJ
    Genes Chromosomes Cancer; 2000 Feb; 27(2):191-5. PubMed ID: 10612808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.
    García-Castellano JM; Villanueva A; Healey JH; Sowers R; Cordon-Cardo C; Huvos A; Bertino JR; Meyers P; Gorlick R
    Clin Cancer Res; 2002 Mar; 8(3):782-7. PubMed ID: 11895909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent deletion in the methylthioadenosine phosphorylase gene in T-cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy.
    Batova A; Diccianni MB; Nobori T; Vu T; Yu J; Bridgeman L; Yu AL
    Blood; 1996 Oct; 88(8):3083-90. PubMed ID: 8874207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
    Chen ZH; Olopade OI; Savarese TM
    Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Codeletion of the genes for p16INK4, methylthioadenosine phosphorylase, interferon-alpha1, interferon-beta1, and other 9p21 markers in human malignant cell lines.
    Zhang H; Chen ZH; Savarese TM
    Cancer Genet Cytogenet; 1996 Jan; 86(1):22-8. PubMed ID: 8616780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
    Chen ZH; Zhang H; Savarese TM
    Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.
    Nobori T; Takabayashi K; Tran P; Orvis L; Batova A; Yu AL; Carson DA
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6203-8. PubMed ID: 8650244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylthioadenosine phosphorylase (MTAP) in hearing: gene disruption by chromosomal rearrangement in a hearing impaired individual and model organism analysis.
    Williamson RE; Darrow KN; Michaud S; Jacobs JS; Jones MC; Eberl DF; Maas RL; Liberman MC; Morton CC
    Am J Med Genet A; 2007 Jul; 143A(14):1630-9. PubMed ID: 17534888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types.
    Gursky S; Olopade OI; Rowley JD
    Cancer Genet Cytogenet; 2001 Sep; 129(2):93-101. PubMed ID: 11566337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The methylthioadenosine phosphorylase gene is frequently co-deleted with the p16INK4a gene in acute type adult T-cell leukemia.
    Hori Y; Hori H; Yamada Y; Carrera CJ; Tomonaga M; Kamihira S; Carson DA; Nobori T
    Int J Cancer; 1998 Jan; 75(1):51-6. PubMed ID: 9426690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of methylthioadenosine phosphorylase and elevated ornithine decarboxylase is common in pancreatic cancer.
    Subhi AL; Tang B; Balsara BR; Altomare DA; Testa JR; Cooper HS; Hoffman JP; Meropol NJ; Kruger WD
    Clin Cancer Res; 2004 Nov; 10(21):7290-6. PubMed ID: 15534104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
    Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
    Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M; Malicki D; Nobori T; Rosenbach MD; Campbell K; Carson DA; Carrera CJ
    Oncogene; 1998 Nov; 17(20):2669-75. PubMed ID: 9840931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.
    Powell EL; Leoni LM; Canto MI; Forastiere AA; Iocobuzio-Donahue CA; Wang JS; Maitra A; Montgomery E
    Am J Surg Pathol; 2005 Nov; 29(11):1497-504. PubMed ID: 16224217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.
    Menezes WP; Silva VAO; Gomes INF; Rosa MN; Spina MLC; Carloni AC; Alves ALV; Melendez M; Almeida GC; Silva LSD; Clara C; da Cunha IW; Hajj GNM; Jones C; Bidinotto LT; Reis RM
    Cells; 2020 Feb; 9(2):. PubMed ID: 32093414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells.
    Efferth T; Miyachi H; Drexler HG; Gebhart E
    Blood Cells Mol Dis; 2002; 28(1):47-56. PubMed ID: 11987241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of methylthioadenosine phosphorylase activity to select for human chromosome 9 in interspecies and intraspecies hybrid cells.
    Porterfield BW; Pomykala H; Maltepe E; Bohlander SK; Rowley JD; Diaz MO
    Somat Cell Mol Genet; 1993 Sep; 19(5):469-77. PubMed ID: 7507266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.